NO20053348D0 - Farmasoytisk sammensetning for behandling av virusangrep. - Google Patents

Farmasoytisk sammensetning for behandling av virusangrep.

Info

Publication number
NO20053348D0
NO20053348D0 NO20053348A NO20053348A NO20053348D0 NO 20053348 D0 NO20053348 D0 NO 20053348D0 NO 20053348 A NO20053348 A NO 20053348A NO 20053348 A NO20053348 A NO 20053348A NO 20053348 D0 NO20053348 D0 NO 20053348D0
Authority
NO
Norway
Prior art keywords
treatment
pharmaceutical composition
viral attacks
attacks
viral
Prior art date
Application number
NO20053348A
Other languages
English (en)
Other versions
NO20053348L (no
Inventor
Takuo Tsukuda
Masahiro Aoki
Hideyuki Kato
Masayuki Sudoh
Miyako Masubuchi
Kenichi Kawasaki
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of NO20053348D0 publication Critical patent/NO20053348D0/no
Publication of NO20053348L publication Critical patent/NO20053348L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/405Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/70Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/72Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms
    • C07C235/76Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO20053348A 2003-02-12 2005-07-11 Farmasoytisk sammensetning for behandling av virusangrep. NO20053348L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2003034056 2003-02-12
JP2003272420 2003-07-09
PCT/JP2004/001498 WO2004071503A1 (ja) 2003-02-12 2004-02-12 ウイルス治療薬

Publications (2)

Publication Number Publication Date
NO20053348D0 true NO20053348D0 (no) 2005-07-11
NO20053348L NO20053348L (no) 2005-09-12

Family

ID=32871168

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20053348A NO20053348L (no) 2003-02-12 2005-07-11 Farmasoytisk sammensetning for behandling av virusangrep.

Country Status (15)

Country Link
US (2) US7776918B2 (no)
EP (1) EP1593378B1 (no)
JP (1) JP3921227B2 (no)
KR (1) KR101071014B1 (no)
AU (1) AU2004211850B2 (no)
BR (1) BRPI0407140A (no)
CA (1) CA2515370C (no)
IL (1) IL169551A (no)
MX (1) MXPA05008507A (no)
MY (1) MY141506A (no)
NO (1) NO20053348L (no)
NZ (1) NZ542250A (no)
RU (1) RU2350600C2 (no)
TW (1) TWI335219B (no)
WO (1) WO2004071503A1 (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1661882B1 (en) * 2003-07-09 2013-10-30 Chugai Seiyaku Kabushiki Kaisha Compound having anti-HCV activity and process for producing the same
EP1795206A4 (en) * 2004-08-11 2009-07-22 Chugai Pharmaceutical Co Ltd MEDICAMENT FOR THE TREATMENT OR PREVENTION OF HCV INFECTION
JP2006077004A (ja) * 2004-08-11 2006-03-23 Chugai Pharmaceut Co Ltd 抗hcv作用を有する化合物およびそれを含む医薬組成物
US7897783B2 (en) * 2005-02-17 2011-03-01 Chugai Seiyaku Kabushiki Kaisha Intermediate compound for synthesis of viridiofungin a derivative
US20110098477A1 (en) * 2005-06-28 2011-04-28 Chugai Seiyaku Kabushiki Kaisha Method Of Producing Compound Having Anti-Hcv Activity
EP2042188A4 (en) 2006-05-16 2011-11-16 Tokyo Metropolitan Org Med Res PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PREVENTION OF HCV INFECTION
TW201010692A (en) * 2008-06-19 2010-03-16 Public Univ Corp Nagoya City Univ Pharmaceutical composition for treatment or prevention of hbv infection
EP2610343A3 (en) 2008-11-26 2013-09-25 Chugai Seiyaku Kabushiki Kaisha Method for designing siRNA and oligoribonucleotides inhibiting HCV
JP2013121935A (ja) 2011-12-12 2013-06-20 Institute Of Microbial Chemistry 化合物、及び不斉合成反応
WO2014027696A1 (ja) 2012-08-17 2014-02-20 中外製薬株式会社 抗hcv作用を有する経口投与可能なビリジオファンジン誘導体
JP5933867B1 (ja) * 2016-03-28 2016-06-15 公益財団法人微生物化学研究会 化合物、及び不斉合成反応
CN114105855B (zh) * 2020-08-31 2024-03-15 中国科学院大连化学物理研究所 一种在吲哚c2位引入异戊烯基的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU770012A1 (ru) * 1979-05-21 1982-01-23 Ордена Трудового Красного Знамени Институт Высокомолекулярных Соединений Ан Ссср D,L-или L-N-метакрилоилтриптофан в качестве мономера дл получени полимеров с ковалентно присоединенными триптофановыми группами
US5364948A (en) * 1991-08-02 1994-11-15 Merck & Co., Inc. Biologically active compounds isolated from aerobic fermentation of Trichoderma viride
EP0526936A3 (en) * 1991-08-02 1993-05-05 Merck & Co. Inc. Cholesterol-lowering agents
US5503973A (en) 1992-05-29 1996-04-02 The Regents Of The University Of California Method for inhibition of viral morphogenesis
EP1002793B1 (en) * 1997-06-09 2003-09-24 Takara Bio Inc. Physiologically active substances tkr2449, process for producing the same, and microorganism

Also Published As

Publication number Publication date
EP1593378A4 (en) 2009-05-06
MXPA05008507A (es) 2005-10-20
NO20053348L (no) 2005-09-12
US20060217434A1 (en) 2006-09-28
TWI335219B (en) 2011-01-01
EP1593378B1 (en) 2013-09-25
WO2004071503A1 (ja) 2004-08-26
CA2515370A1 (en) 2004-08-26
JPWO2004071503A1 (ja) 2006-06-01
AU2004211850B2 (en) 2009-06-04
KR20050098929A (ko) 2005-10-12
JP3921227B2 (ja) 2007-05-30
TW200501940A (en) 2005-01-16
HK1095036A1 (zh) 2007-04-20
US7776918B2 (en) 2010-08-17
US20100274026A1 (en) 2010-10-28
IL169551A (en) 2011-10-31
KR101071014B1 (ko) 2011-10-06
RU2005128297A (ru) 2006-02-27
CA2515370C (en) 2012-01-17
AU2004211850A1 (en) 2004-08-26
AU2004211850A2 (en) 2009-02-12
MY141506A (en) 2010-05-14
NZ542250A (en) 2008-12-24
EP1593378A1 (en) 2005-11-09
RU2350600C2 (ru) 2009-03-27
BRPI0407140A (pt) 2006-02-07

Similar Documents

Publication Publication Date Title
LT2878297T (lt) Medikamentai, skirti fibrozinių ligų gydymui arba prevencijai
IS8398A (is) Lyfjasamsetningar til að meðhöndla æxli
NO20052058D0 (no) Behandling av influensa.
DK1716162T3 (da) Phosphonater, amidomonophosphonater, amidobisphosphonater til behandling af virussygdomme
NO20052580D0 (no) Blandinger for behandling av infeksjon av Flavivirida viruser
ATE541845T1 (de) 2,3-substituierte azaindolderivate zur behandlung von virusinfektionen
NO2014009I2 (no) Forbindelser, farmasøytiske sammensetninger og anvendelser derav, samt fremgangsmåte for å fremstille nevnte forbindelser
NO20052306D0 (no) Dispergerbare farmasoytiske blandinger.
DK1765391T3 (da) Bakterielle præparater til behandlingen af cancer
EP1594512A4 (en) COMPOUNDS FOR THE TREATMENT OF VIRUS INFECTIONS
IS7691A (is) Lyfjasamsetningar til að meðhöndla æxli
PL376454A1 (en) 1-acyl-pyrrolidine derivatives for the treatment of viral infections
NO20053211D0 (no) Forbindelser for behandling av metabolske forstyrrelser.
DK1499730T3 (da) Immunokonjugater til behandling af tumorer
DE602006017980D1 (de) 3,4-substituierte pyrrolidin-derivate zur behandlung von hypertonie
CL2004000261A1 (es) Procedimiento para la eliminacion de virus en soluciones de fibrinogeno de aplicacion terapeutica.
EP1692279A4 (en) VIRUS PREPARATIONS CONTAINING A CONSERVATIVE
ATE380557T1 (de) E. coli vakzin zur protektion von geflügel gegen colibazillose
DE602006003094D1 (de) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin-derivate zur behandlung von unfruchtbarkeit
DK2042182T3 (da) Farmaceutisk sammensætning, der omfatter arsen, til behandling af malignitet.
DE602006002608D1 (de) 4-phenyl-5-oxo-l,4,5,6,7,8-hexahydrochinolin-derivate als arzneimittel zur behandlung von unfruchtbarkeit
NO20054034D0 (no) Fremgangsmate for behandling av hypotyroidisme.
DE602004010172D1 (de) Pharmazeutische zusammensetzungen zur behandlung von nierenfunktionsstörungen
DK1567524T3 (da) Thia-epothilonderivater til behandling af cancer
ATA10872004A (de) Pharmazeutische zubereitung zur behandlung von schock

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application